Atrial natriuretic peptide in heart failure
- 31 October 1993
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 22 (4), A86-A92
- https://doi.org/10.1016/0735-1097(93)90468-g
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Interaction of atrial natriuretic polypeptide and angiotensin II on protooncogene expression and vascular cell growthBiochemical and Biophysical Research Communications, 1991
- Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)Science, 1991
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation, 1990
- Renal-endocrine adaptations to endogenous atrial natriuretic factor during tachycardia-induced reductions in renal perfusion pressure.Circulation Research, 1990
- Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor.Circulation Research, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981